Clinical Trials Directory

Trials / Completed

CompletedNCT01490515

Embryo Selection Using Non-invasive Metabolomic Analysis Versus Morphology

Embryo Selection Using Non-invasive Metabolomic Analysis Indicates Improvement in Implantation Rates With Fetal Cardiac Activity

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
125 (actual)
Sponsor
Eugonia · Academic / Other
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

Metabolomics was recently introduced in human IVF for non-invasive identification of viable embryos with the highest developmental competence. The investigators intended to investigate if embryo assessment using non-invasive metabolomic profiling leads to increased implantation rates compared to routine morphology evaluation alone.

Detailed description

Metabolomics was recently introduced in human IVF for non-invasive identification of viable embryos with the highest developmental competence. The aim of the present study was to determine whether embryo selection using non-invasive metabolomic profiling as an adjunct to morphology leads to increased implantation rates compared to routine morphology evaluation alone.

Conditions

Interventions

TypeNameDescription
PROCEDUREnon-invasive metabolomic profilingnon-invasive metabolomic profiling of IVF human embryos
OTHERmorphological evaluationSimple microscopic observation of embryos and evaluation of morphological characteristics

Timeline

Start date
2010-04-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2011-12-13
Last updated
2013-12-16

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01490515. Inclusion in this directory is not an endorsement.